Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
EVO
EVO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EVO News
Evotec-Almirall Team Advances Small Molecule Program to Preclinical Development
6d ago
Yahoo Finance
Evotec to Announce Q1 2026 Financial Results on May 6
Apr 29 2026
Yahoo Finance
Evotec CFO Paul Hitchin Resigns, Claire Hinshelwood Appointed
Apr 24 2026
NASDAQ.COM
Evotec Appoints New Chief Operating Officer
Apr 15 2026
Yahoo Finance
Evotec (EVO) Q3 2025 Earnings Call Transcript
Apr 08 2026
NASDAQ.COM
Evotec SE Reports Significant Revenue and Cost Savings in 2025
Apr 08 2026
Yahoo Finance
Evotec Nominates New Chairman for Supervisory Board
Apr 07 2026
NASDAQ.COM
Evotec Appoints New Chief Commercial Officer
Apr 01 2026
Yahoo Finance
Evotec's Biologics Unit Selected by US Government
Mar 23 2026
Yahoo Finance
Evotec and BMS Initiate Phase 1 Clinical Trial for Kidney Cancer Treatment
Mar 19 2026
Yahoo Finance
Investigation Launched into Evotec SE for Potential Investor Claims
Mar 11 2026
Globenewswire
Evotec Launches Strategic Transformation Initiative 'Horizon'
Mar 10 2026
Benzinga
U.S. Stocks Mixed in Morning Trading
Mar 10 2026
Benzinga
Zevra Therapeutics Reports Strong Q4 Earnings, Shares Surge
Mar 10 2026
Benzinga
DaVita Reports Strong Q4 Earnings, Shares Surge 21.7%
Feb 03 2026
Benzinga
Amgen Acquires Dark Blue Therapeutics for Up to $840 Million
Jan 07 2026
Benzinga
Show More News
